{"id":45361,"date":"2022-06-22T16:01:31","date_gmt":"2022-06-22T14:01:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/"},"modified":"2022-06-22T16:01:31","modified_gmt":"2022-06-22T14:01:31","slug":"qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/","title":{"rendered":"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality"},"content":{"rendered":"
\n

STOCKHOLM & HOUSTON–(BUSINESS WIRE)–Today, Qbtech<\/a> announces a partnership in The Netherlands with one of the leading ADHD care providers, ADHDcentraal<\/a>. The purpose of the collaboration is to create new methods and tools that allow patients to access high-quality care readily, something that is not possible today.\n<\/p>\n

<\/a><\/p>\n

\nAs an innovator in ADHD, Qbtech has enjoyed working with forward-thinking organizations also looking to make quality ADHD care accessible. ADHDcentraal has established itself as a leader not only in ADHD care but also in Digital Health, providing patients access to telehealth services, including Qbtech\u2019s technology, QbCheck, which allows clinicians to collect objective data on ADHD symptoms from patients at home.\n<\/p>\n

\n\u201cWe\u2019ve worked with Qbtech for 10 years now. Bringing their technology into practice has been invaluable in supporting our clinical decision-making and helping patients better understand their symptoms, whether ADHD is ruled in or ruled out as a potential diagnosis,\u201d says Jan-Eidse van Melle, CEO of ADHDcentraal. \u201cTheir adaptability in bringing their technology to patients\u2019 homes during the pandemic supported us in continuing to provide care despite the restrictions. Looking ahead, we see this as a natural partnership and a commitment to ongoing innovation to provide the best standard of care for our patients.\u201d\n<\/p>\n

\nAs patients and clinicians seek more flexibility, this partnership confirms the organizations\u2019 shared commitment to drive ADHD care forwards. The partnership will initially focus on treatment optimization to improve the quality of life for patients with ADHD and enable healthcare professionals to support them.\n<\/p>\n

\n\u201cThis partnership symbolizes the synergy between our two organizations. We\u2019re both passionate about better standards in ADHD care and increasing access via Digital Health solutions. We see this partnership as a natural progression of our existing relationship, aligning our combined energies to focus on a common cause,\u201d shares Carl Reuterski\u00f6ld, CEO of Qbtech. \u201cThis partnership will involve a collaborative approach to rethink how best ADHD care can be delivered through digital solutions while maximizing the value of one-to-one clinician appointments, both face-to-face and virtual. We are excited to work toward better outcomes to meet contemporary clinical and patient needs.\u201d\n<\/p>\n

\nAbout Qbtech<\/b>\n<\/p>\n

\nFounded in 2002, Qbtech is a privately-owned Swedish company that has developed leading solutions and products for improving the diagnosis, treatment and follow-up of patients living with ADHD. Qbtech has operations in 13 countries and has offices in Stockholm, Houston, and London. Qbtech is an award-winning company recognized for their innovation, most recently winning the 2022 HSJ Partnership Award for the \u2018Best Mental Health Partnership with the NHS\u2019. www.qbtech.com<\/a>\n<\/p>\n

\nAbout ADHDcentraal<\/b>\n<\/p>\n

\nADHDcentraal is a leading healthcare provider in ADHD care in the Netherlands, specialised in Adult ADHD care. Building on over 15 years of experience, ADHDcentraal sees over 9,000 new patients each year across multiple locations. Their team consists solely of specialists in the field of ADHD, offering a unique program of assessment and treatment. ADHDcentraal ranks amongst the highest in client satisfaction scores (9.3\/10) and effectiveness (over 50% improvement in quality of life measured by the AAQoL) among Dutch healthcare providers, while achieving an insurer\u2019s cost per treatment significantly (34%) below the Dutch average. ADHDcentraal conducts research within its R&D department, and in cooperation with other clinics and universities, aimed at improving care for ADHD patients worldwide.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor Qbtech:
\n
Hilari Barton
\n
Trevelino\/Keller
\n
hnbarton@trevelinokeller.com<\/a>\n<\/p>\n

\nFor ADHDCentraal:
\n
Jorg Heijmink Liesert
\n
jorgheijmink@adhdcentraal.nl<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

STOCKHOLM & HOUSTON–(BUSINESS WIRE)–Today, Qbtech announces a partnership in The Netherlands with one of the leading ADHD care providers, ADHDcentraal. The purpose of the collaboration is to create new methods and tools that allow patients to access high-quality care readily, something that is not possible today. As an innovator in ADHD, Qbtech has enjoyed working … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45361","6":"format-standard","7":"category-industry"},"yoast_head":"\nQbtech Partners with Leading ADHD Provider to Transform Access and Quality - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"STOCKHOLM & HOUSTON–(BUSINESS WIRE)–Today, Qbtech announces a partnership in The Netherlands with one of the leading ADHD care providers, ADHDcentraal. The purpose of the collaboration is to create new methods and tools that allow patients to access high-quality care readily, something that is not possible today. As an innovator in ADHD, Qbtech has enjoyed working ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-22T14:01:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220622005690\/en\/1274411\/21\/Qbtech_Colour_wstrap.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality\",\"datePublished\":\"2022-06-22T14:01:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/\"},\"wordCount\":565,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005690\\\/en\\\/1274411\\\/21\\\/Qbtech_Colour_wstrap.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/\",\"name\":\"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005690\\\/en\\\/1274411\\\/21\\\/Qbtech_Colour_wstrap.jpg\",\"datePublished\":\"2022-06-22T14:01:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005690\\\/en\\\/1274411\\\/21\\\/Qbtech_Colour_wstrap.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005690\\\/en\\\/1274411\\\/21\\\/Qbtech_Colour_wstrap.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/","og_locale":"en_US","og_type":"article","og_title":"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality - Pharma Trend","og_description":"STOCKHOLM & HOUSTON–(BUSINESS WIRE)–Today, Qbtech announces a partnership in The Netherlands with one of the leading ADHD care providers, ADHDcentraal. The purpose of the collaboration is to create new methods and tools that allow patients to access high-quality care readily, something that is not possible today. As an innovator in ADHD, Qbtech has enjoyed working ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-22T14:01:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220622005690\/en\/1274411\/21\/Qbtech_Colour_wstrap.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality","datePublished":"2022-06-22T14:01:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/"},"wordCount":565,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220622005690\/en\/1274411\/21\/Qbtech_Colour_wstrap.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/","url":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/","name":"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220622005690\/en\/1274411\/21\/Qbtech_Colour_wstrap.jpg","datePublished":"2022-06-22T14:01:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220622005690\/en\/1274411\/21\/Qbtech_Colour_wstrap.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220622005690\/en\/1274411\/21\/Qbtech_Colour_wstrap.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/qbtech-partners-with-leading-adhd-provider-to-transform-access-and-quality\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Qbtech Partners with Leading ADHD Provider to Transform Access and Quality"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45361"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45361\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}